Latest Articles about MDCI

Company News for June 12, 2013 - Corporate Summary

Zacks Equity Research — Wed, 12 Jun 2013 18:06:01 Z

• Shares of Sprint Corporation (NYSE: S ) increased 2.4% after SoftBank Corp increased its buyout bid from $20.1 billion to $21.6 billion • Shares of

Stock Upgrades: The Walt Disney Company Tries to Engineer a Turnaround Tuesday

Justin Sharon — Tue, 11 Jun 2013 17:23:00 Z

Rainy Days and Mondays combined to bring the Dow (^DJI) down, despite the best efforts of its key component Travelers ( TRV ) - longtime logo: an umbrella - to enliven proceedings with

New Stock Coverage: Time to Shop at Casey's General Stores, Inc.

Justin Sharon — Tue, 11 Jun 2013 17:18:00 Z

A two-time Sports Illustrated swimsuit issue supermodel, whose ascendancy has been good for equities , turned the legal drinking age yesterday , only to find Mr. Market suffering a serious

Pre-Market Earnings Report for June 11, 2013 : PBY, MDCI, LDK

NASDAQ.com News — Tue, 11 Jun 2013 00:00:04 Z

The following companies are expected to report earnings prior to market open on 06/11/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Pep Boys-Manny, Moe

Weekly Preview: Retail Sales, Lululemon Earnings to Drive Markets

Matthew Kanterman — Sat, 08 Jun 2013 00:28:13 Z

The next week brings a relatively light week on the data front, with few earnings and scarce data economic data marking the calendar. The May retail sales report on Thursday and earnings from

Reiterate Baxter at Neutral - Analyst Blog

Zacks Equity Research — Tue, 23 Apr 2013 23:10:54 Z

On Apr 22, we reiterated Baxter International ( BAX ) at Neutral, based on the company's narrow beat of the Zacks Consensus Estimate for earnings. We also noted the company's maintenance of

Reiterate Intuitive at Neutral - Analyst Blog

Zacks Equity Research — Tue, 23 Apr 2013 22:09:45 Z

On Apr 22, we retained Intuitive Surgical, Inc. ( ISRG ) at Neutral after the company reported favorable results for the first quarter 2013. In addition, ISRG made adjustments to its

New Bioinformatics Tools by LIFE - Analyst Blog

Zacks Equity Research — Wed, 10 Apr 2013 23:10:10 Z

Life Technologies Corporation ( LIFE ) recently revealed a couple of new bioinformatics solutions. These offerings will work on the Oncomine platform, which was added to the company's

Quest Closes HemoCue Divestment - Analyst Blog

Zacks Equity Research — Wed, 10 Apr 2013 17:06:30 Z

As per its plan to sell the HemoCue diagnostics products business, Quest Diagnostics ( DGX ), recently completed the divesture of the same. The company announced that Radiometer Medical ApS

CYBX Resumes Reimbursement Efforts - Analyst Blog

Zacks Equity Research — Mon, 08 Apr 2013 23:07:35 Z

Cyberonics ( CYBX ) recently provided further information on its reimbursement claim submission to the Centers for Medicare & Medicaid Services (CMS). The leading player in the

Medtronic Remains at Neutral - Analyst Blog

Zacks Equity Research — Fri, 05 Apr 2013 22:09:12 Z

We recently reinstated our Neutral recommendation on Medtronic, Inc. ( MDT ), a leading medical devices company. While we are to-some-extent relieved with the signs of stability in

Still Neutral on Merge Healthcare - Analyst Blog

Zacks Equity Research — Fri, 05 Apr 2013 22:07:18 Z

On Apr 2, 2013, we reaffirmed our long-term Neutral recommendation on Merge Healthcare Incorporated ( MRGE ) as the company's bright growth prospects are to some extent dwarfed by

Boston Scientific Stays at Neutral - Analyst Blog

Zacks Equity Research — Thu, 04 Apr 2013 23:10:09 Z

We recently reinstated our Neutral recommendation on Boston Scientific Corporation ( BSX ), a leading medical devices company. After several quarters of weak performance, we are encouraged

LIFE Grows AmpliSeq Portfolio - Analyst Blog

Zacks Equity Research — Thu, 04 Apr 2013 00:20:36 Z

Global biotechnology tools company - Life Technologies Corp ( LIFE ) continued the expansion of its Ion AmpliSeq portfolio with the recent launch of two Ion AmpliSeq Community Panel designs

FDA Clears Affinity, Boosts MDT's Biz - Analyst Blog

Zacks Equity Research — Wed, 03 Apr 2013 22:22:09 Z

The recent US Food and Drug Administration ("FDA") 510(k) clearance for Affinity Fusion oxygenation system has enhanced the structural heart business of medical devices major -